Dechra makes success of debut in PP market
Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has sold euro and dollar US private placement notes, in a debut widely seen as a success.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: